A study was undertaken in North Arcot and Raichur districts in South India to find out the reasons for patients getting ‘lost’ from short course chemotherapy. There were 545 (40%) patients ‘lost’ from treatment in North Arcot during 14 months and 219 (46%) in Raichur during 72 months. Approximately half of the ‘lost’ patients from both the districts discontinued treatment within two months from the start of treatment. Due to inadequate or incorrect address, 84 (15%) and 26 (13%) patients could not be traced at North Arcot and Raichur, respectively. Reasons could not be elicited from 39 (7%) and 16 (7%) patients, respectively, as they had migrated. Eighty-two (15%) from North Arcot and 33 (15%) from Raichur had died. For 55 (10%) pat...
In North Arcot district, where Short Course Chemotherapy (SCC) had been introduced in 1983, a cros...
In a total of 2,332 pulmonary short-course chemotherapy studies conducted during 1975-1985, there ...
Objectives: To elicit reasons for treatment default from a cohort of TB patients under RNTCP and the...
The ICMR undertook a study project to find out the feasibility of introducing Short-Course Chemother...
Background: TB is one of the most ancient diseases. World Health Organization (WHO) estimated 9.2 mi...
Background: Tuberculosis is a major cause of death in India. Premature cessation of treatment in tub...
Background: India has been engaged in TB control activities for more than 50 years. Yet TB continues...
This article presents the results of a controlled clinical study of 3 shortcourse regimens conducted...
Background: Pretreatment loss to follow-up (PTLFU) is a barrier to tuberculosis (TB) control in Indi...
Background: M .tuberculosis is an ancient infectious killer that still remains one of the leading ca...
Background: Revised National Tuberculosis Control Programme (RNTCP) based on Directly Observed Treat...
Multidrug-resistant Tuberculosis (MDR-TB) is a rising global threat to public health and concerted e...
A total of 395 TB meningitis patients were admitted for treatment comprising regimens containing Rif...
Background: India's Revised National Tuberculosis (TB) Control Programme (RNTCP) offers free TB diag...
We studied the proportion and fate of tuberculosis patients who were not initiated on treatment (ini...
In North Arcot district, where Short Course Chemotherapy (SCC) had been introduced in 1983, a cros...
In a total of 2,332 pulmonary short-course chemotherapy studies conducted during 1975-1985, there ...
Objectives: To elicit reasons for treatment default from a cohort of TB patients under RNTCP and the...
The ICMR undertook a study project to find out the feasibility of introducing Short-Course Chemother...
Background: TB is one of the most ancient diseases. World Health Organization (WHO) estimated 9.2 mi...
Background: Tuberculosis is a major cause of death in India. Premature cessation of treatment in tub...
Background: India has been engaged in TB control activities for more than 50 years. Yet TB continues...
This article presents the results of a controlled clinical study of 3 shortcourse regimens conducted...
Background: Pretreatment loss to follow-up (PTLFU) is a barrier to tuberculosis (TB) control in Indi...
Background: M .tuberculosis is an ancient infectious killer that still remains one of the leading ca...
Background: Revised National Tuberculosis Control Programme (RNTCP) based on Directly Observed Treat...
Multidrug-resistant Tuberculosis (MDR-TB) is a rising global threat to public health and concerted e...
A total of 395 TB meningitis patients were admitted for treatment comprising regimens containing Rif...
Background: India's Revised National Tuberculosis (TB) Control Programme (RNTCP) offers free TB diag...
We studied the proportion and fate of tuberculosis patients who were not initiated on treatment (ini...
In North Arcot district, where Short Course Chemotherapy (SCC) had been introduced in 1983, a cros...
In a total of 2,332 pulmonary short-course chemotherapy studies conducted during 1975-1985, there ...
Objectives: To elicit reasons for treatment default from a cohort of TB patients under RNTCP and the...